This webinar explores how integrated laboratory and real-world data (RWD) are helping accelerate diagnosis, patient identification, clinical trial recruitment, and commercialization. Norstella and Quest Diagnostics highlight how linked claims, lab, EMR, and unstructured data support precision medicine, physician targeting, and earlier disease detection across oncology, neurology, rare disease, and autoimmune conditions. The discussion also covers the growing role of AI and NLP in uncovering predictive insights and building clinically meaningful patient cohorts, while emphasizing the importance of data quality, harmonization, and clinically grounded analytics to help move therapies from pipeline to patients faster.
You’ll learn:
- The many ways that pharma companies can leverage in-depth lab data to target patients and providers.
- How to use insights like treatment response and risk level to build patient triggers.
- Why it’s important to understand patient trends, such as progression toward a disease state or advancement of a disease after diagnosis.
- Ways that lab data can work with other data sources—like claims or coverage data—to paint a full picture of the patient journey, and how to use it effectively.
- And more…